Health Durvalumab & SCLC: Survival Boost, But Is It Worth the Cost? by Grace O’Connor — Health & Science Editor 20/01/2026 by Grace O’Connor — Health & Science Editor 20/01/2026 A significant, yet predictably complex, victory has emerged in the fight against small cell lung cancer (SCLC). New data from the ADRIATIC …
